Stocks of the Hour: Jindalee Lithium, Algorae Pharmaceuticals, Canyon Resources
Stocks of the Hour: Jindalee Lithium, Algorae Pharmaceuticals, Canyon Resources
To register for Friday's webinar click here.
请点击此处注册星期五的网络研讨会。
Jindalee Lithium (ASX:JLL) announced that battery-grade lithium carbonate has been successfully produced from ore from the McDermitt Lithium Project. All steps of the processing flowsheet for the Project from ore beneficiation and leaching to purification and production of battery-grade lithium carbonate are now validated. Shares are trading 13.46 per cent higher at 29.5 cents.
Jindalee锂矿(ASX:JLL)宣布,成功从McDermitt锂矿项目的矿石中生产出电池级碳酸锂。该项目从矿石选矿、浸出、纯化到生产电池级碳酸锂的所有过程都已经验证。股价上涨13.46%,报0.295澳元。
Algorae Pharmaceuticals (ASX:1AI) has released positive results for its drug AI-116. It showed significantly better results in reducing brain cell damage than an existing dementia drug in laboratory tests. Shares are trading 33.33 per cent higher at 1.2 cents.
Algorae制药公司(ASX:1AI)发布了其AI-116药物的积极成果。在实验室测试中,它显示出比现有的治疗痴呆症的药物在减轻大脑细胞损伤方面有显著更好的效果。股价上涨33.33%,报0.012澳元。
Canyon Resources (ASX:CAY) has signed a mining convention for the Minim-Martap Bauxite Project in Cameroon. This agreement outlines how Canyon's subsidiary can mine and export alumina and bauxite once it receives a mining permit. Shares are trading 2.67 per cent higher at 7.7 cents.
Canyon资源(ASX:CAY)已经为喀麦隆Minim-Martap铝土矿项目签署了采矿公约。协议规定,在Canyon的子公司获得采矿许可证后,可以采矿和出口铝土和氧化铝。股价上涨2.67%,报0.077澳元。